Similar articles for PMID: 3001928

Year	Number of Results
1982	4
1983	3
1984	4
1985	7
1986	11
1987	6
1988	7
1989	4
1990	5
1991	2
1992	4
1993	6
1994	3
1995	5
1996	1
1997	2
1998	3
1999	1
2000	3
2001	2
2003	1
2006	3
2007	1
2008	3
2009	1
2011	1
2013	1
2020	1
2022	0

1

Epstein-Barr virus-transformed B cell lines present M. leprae antigens to T cells.

Elferink BG, Ottenhoff TH, de Vries RR. Elferink BG, et al. Scand J Immunol. 1985 Nov;22(5):585-9. doi: 10.1111/j.1365-3083.1985.tb01918.x. Scand J Immunol. 1985. PMID: 3001928

2

Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.

Yamamoto M, Yano A. Yamamoto M, et al. J Immunol. 1985 Dec;135(6):3887-96. J Immunol. 1985. PMID: 2999233

3

Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein.

Mustafa AS, Lundin KE, Meloen RH, Oftung F. Mustafa AS, et al. Clin Exp Immunol. 2000 Apr;120(1):85-92. doi: 10.1046/j.1365-2249.2000.01156.x. Clin Exp Immunol. 2000. PMID: 10759768 Free PMC article.

4

Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.

Ramadan G. Ramadan G. Egypt J Immunol. 2008;15(1):145-57. Egypt J Immunol. 2008. PMID: 20306679

5

Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.

Reitnauer PJ, Brown LR, Hank JA, Sondel PM. Reitnauer PJ, et al. Cell Immunol. 1986 Apr 15;99(1):196-208. doi: 10.1016/0008-8749(86)90228-5. Cell Immunol. 1986. PMID: 3019572

6

EBV transformed B cell lines present to antigen specific T cell clones determinants different from those recognized by antibody in an HLA-DR linked restricted fashion.

Chu E, Umetsu D, Yunis E, Geha RS. Chu E, et al. Hum Immunol. 1983 Nov;8(3):217-26. doi: 10.1016/0198-8859(83)90039-3. Hum Immunol. 1983. PMID: 6196340

7

Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.

Topalian SL, Rivoltini L, Mancini M, Ng J, Hartzman RJ, Rosenberg SA. Topalian SL, et al. Int J Cancer. 1994 Jul 1;58(1):69-79. doi: 10.1002/ijc.2910580113. Int J Cancer. 1994. PMID: 7516926

8

Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cells.

Mandell RB, Hank JA, Chen BP, Robins HI, Sondel PM. Mandell RB, et al. Hum Immunol. 1987 Jul;19(3):163-77. doi: 10.1016/0198-8859(87)90067-x. Hum Immunol. 1987. PMID: 3040644

9

HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cells.

Haanen JB, Ottenhoff TH, Voordouw A, Elferink BG, Klatser PR, Spits H, De Vries RR. Haanen JB, et al. Scand J Immunol. 1986 Jan;23(1):101-8. doi: 10.1111/j.1365-3083.1986.tb01947.x. Scand J Immunol. 1986. PMID: 2422737

10

Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.

Zhu F, Ramadan G, Davies B, Margolis DA, Keever-Taylor CA. Zhu F, et al. Clin Exp Immunol. 2008 Feb;151(2):284-96. doi: 10.1111/j.1365-2249.2007.03544.x. Epub 2007 Nov 14. Clin Exp Immunol. 2008. PMID: 18005260 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed